Management of Opioid-Induced Hyperalgesia in Seniors
Recognizing and Managing Opioid-Induced Hyperalgesia
- Pain becomes more diffuse or spreads beyond the original site in patients on opioids, indicating potential opioid-induced hyperalgesia, according to the Mayo Clinic Proceedings 1
- The American Geriatrics Society recommends suspecting opioid-induced hyperalgesia when pain escalates despite increasing opioid doses, and there is no evidence of disease progression, with a strength of evidence supported by case series and preclinical trials 3
Multimodal Analgesic Protocol for Seniors
- The World Journal of Emergency Surgery suggests implementing a comprehensive multimodal approach to minimize opioid requirements, including non-opioid systemic analgesics, adjuvant analgesics, and regional analgesia techniques, with a strength of evidence endorsed by the 2024 WSES guidelines 2
- The Mayo Clinic Proceedings recommends using acetaminophen 650-1000 mg every 6-8 hours scheduled for baseline analgesia, and avoiding systemic NSAIDs due to risks of GI bleeding, acute kidney injury, and cardiovascular events in seniors 1, 4
- The Journal of the American Geriatrics Society recommends starting with duloxetine as first-line adjuvant for neuropathic components, beginning at 30 mg daily and increasing to 60 mg after one week, with a safer profile than tricyclic antidepressants in elderly 3
Senior-Specific Considerations
- The World Journal of Emergency Surgery advises against combining opioids with benzodiazepines, skeletal muscle relaxants, or gabapentinoids outside monitored settings in elderly patients due to compounded CNS depression, fall risk, and respiratory depression 2
- The Mayo Clinic Proceedings recommends prescribing scheduled laxatives prophylactically for any patient on opioids to prevent constipation, which is universal and particularly dangerous in seniors 1, 2
- The Journal of the American Geriatrics Society suggests assessing pain intensity, cognitive function, fall risk, sedation level, bowel function, and renal function at each encounter in seniors on opioids, with a strength of evidence supported by case series and preclinical trials 3, 4